Compare ADMA Biologics Inc (ADMA) vs Oatly Group AB - ADR (OTLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Oatly Group AB - ADR — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Oatly Group AB - ADR trades at $12.93 (market cap $415.98M). The key difference: ADMA Biologics Inc is far larger — about 5.3× Oatly Group AB - ADR's market cap, and Oatly Group AB - ADR is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | OTLY | |
|---|---|---|
Market Cap | $2.22B | $415.98M |
Sector | Health | Consumer Staples |
52-Week High | $20.38 | $18.54 |
52-Week Low | $7.60 | $8.03 |
Enterprise Value | $2.29B | $920.39M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Oatly Group AB - ADR
Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, Icecreams, among others. It caters to Sweden, Germany, United Kingdom, Netherlands, North America, Finland, and other markets.
Read more on OTLY →
